Gland Pharma has received the Securities and Exchange Board of India’s (Sebi) approval to go ahead with its proposed ₹6,000 crore IPO, two people aware of the development said.
from Hindustan Times - business https://ift.tt/3obSylE
via IFTTT
from Hindustan Times - business https://ift.tt/3obSylE
via IFTTT


No comments